Skip to content
Peptigraph home

Sermorelin for Weight Loss: What the Evidence Shows

What human and animal studies show about Sermorelin for weight loss, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGHRH analogUpdated
Strongest evidence
Human observational
Human studies
4
PubMed records, our ledger
Animal studies
0
PubMed records, our ledger
Studies we summarised
1
with an outcome for weight loss

Evidence for weight loss

Each row is an outcome related to weight loss from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Sermorelin for weight loss: outcomes in published studies
OutcomeResultStudy typeSource
Body compositionWeight, BMI, waist-to-hip ratio, DEXA muscle and fat, muscle histology, glucose, insulin and lipids did not change.Human uncontrolled trialn = 11Metabolism: clinical and experimental 1997, PMID 9005976

PubMed records for Sermorelin and weight loss: 4 human, 0 animal (search counts, not studies we reviewed). Grades follow our .

How strong is it?

Strongest evidence:Human observational evidence, 3 of 4Metabolism: clinical and experimental 1997, PMID 9005976

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Weight loss in context

MedlinePlus says reaching and staying at a healthy weight can be challenging.[2]

What was measured for body weight and fat

The weight and body-fat query for sermorelin or Geref (run 2026-10-02) found 5 human-tagged, 4 human-only and 0 animal records, with 1 randomized trial among 6 in all.

Calculated from human 5; human only 4; animal 0; rct 1; all 6. Formula: Counts copied from the sermorelin ledger row of the weight-loss goal in goals.json; no arithmetic.

The nightly GHRH study in older men found no change in weight, BMI, waist-to-hip ratio or DEXA measures of fat.[1]

In the chart review, the men were seeking lean mass and fat loss; the outcome reported was IGF-1, not fat.[3]

A short study in older men reasoned that prolonged treatment could improve body composition, an expectation rather than a result.[4]

Belly fat and the label status

In the one DEXA study, nightly GHRH did not change weight, waist-to-hip ratio or DEXA measures of muscle and fat.[1]

Geref, the labelled sermorelin product, was discontinued by its only US manufacturer, which announced it in July 2008.[5]

Other peptides people research for weight loss

All peptides for weight loss, compared

Common questions

Does Sermorelin help with weight loss?

The strongest study we summarise for weight loss is human observational evidence, across 1 study with an outcome for weight loss. That is not proof it works in people.

Is Sermorelin approved for weight loss?

No. Sermorelin is not FDA approved for any use, including weight loss.

What is the best peptide for weight loss?

There is no single answer. Our weight loss overview compares each candidate by evidence grade and legal status rather than by popularity.

Does sermorelin help you lose weight?

In the nightly-injection study in older men, GHRH did not change weight, BMI, waist-to-hip ratio or DEXA measures of fat.[1]

Does sermorelin burn belly fat?

In the nightly-injection study, waist-to-hip ratio and DEXA measures of fat did not change.[1]

Is sermorelin FDA approved for weight loss?

Geref, the US sermorelin product, was discontinued: its only US manufacturer announced the discontinuation in July 2008.[5]

More on Sermorelin

Sources

  1. 1Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.Metabolism: clinical and experimental · 1997PMID 9005976Accessed 2 Oct 2026
  2. 2Official web pageOfficial web page · web page
  3. 3Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.American journal of men's health · 2017PMID 28830317Accessed 2 Oct 2026
  4. 4Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.The Journal of clinical endocrinology and metabolism · 1992PMID 1379256Accessed 2 Oct 2026
  5. 5Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency?The Journal of clinical endocrinology and metabolism · 2009PMID 19509104Accessed 2 Oct 2026

Found an error? Report a correction.